Bedeutung des Neuraminidase-Inhibitors Oseltamivir in der Therapie der saisonalen Influenza

Schlüsselwörter

Influenza - Epidemie - Neuraminidasehemmer - Oseltamivir - Sekundärkomplikationen

Key words

influenza - epidemic - neuraminidase inhibitors - oseltamivir - secondary complications

Literatur

• 1 Aoki F Y, MacLeod M D, Paggiaro P. et al . Early administration of oral oseltamivir increases the benefits of influenza treatment.  J Antimicrob Chemother. 2003;  51 123-129
• 2 Arbeitsgemeinschaft Influenza. Abschlussberichte der Saisons 2002 - 2007, http://influenza.rki.de/index.html?c = saisonbericht. 
• 3 Barr C E, Schulman K, Iacuzio D. et al . Effect of oseltamivir on the risk of pneumonia and use of health care services in children with clinically diagnosed influenza.  Curr Med Res Opin. 2007;  23 (3) 523-531
• 4 Bhat N, Wright J G, Broder K R. et al . Influenza-associated deaths among children in the United States, 2003 - 2004.  N Engl J Med. 2005;  353 2559-2567
• 5 Falsey A R, Murata Y, Wlash E E. et al . Impact of rapid diagnosis on management of adults hospitalized with influenza.  Arch Intern Med. 2007;  167 (4) 354-360
• 6 Goodwin K, Viboud C, Simonsen S. Antibody response to influenza vaccination in the elderly: A quantitative review.  Vaccine. 2006;  24 1159-1169
• 7 Hayden F G, Atmar R L, Schilling M. et al . Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza.  N Engl J Med. 1999;  341 (18) 1336-1343
• 8 Hayden F G, Treanor J J, Fritz R S. et al . Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment.  JAMA. 1999;  282 1240-1246
• 9 Hayden F G, Robson R, Jennings L. et al . Efficacy of oral oseltamivir in experimental human influenza B virus infection (abstract).  Clin Infect Dis. 1999;  282 1240-1246
• 10 Holm M V, Blank P R, Szucs T. Trends in influenza vaccination coverage rates in Germany over five seasons from 2001 to 2006.  BMC Infect Dis. 2007;  7 144
• 11 Jefferson T. Influenza vaccination: policy versus evidence.  BMJ. 2006;  333 (7574) 912-915
• 12 Jefferson T O, Rivetti D, DiPietrantonj C. et al . Vaccines for preventing influenza in healthy adults.  Cochrane Database Syst Rev. 2007;  (2) , CD001269
• 13 Jefferson T O, Rivetti D, Rivetti A. et al . Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review.  Lancet. 2005;  366 (9492) 1165-74 , Review. Erratum in: Lancet 2006 Mar 25; 367(9515): 986
• 14 Kaiser L, Wat C, Mills T. et al . Impact of oseltamivir treatment on influenza-related respiratory tract complications and hospitalisations.  Arch Intern Med. 2002;  163 1667-1672
• 15 Leitmeyer K, Buchholz U, Kramer M. et al . Influenza vaccination in German health care workers: effects and findings after two rounds of a nationwide awareness campaign.  Vaccine. 2006;  24 70003-70008
• 16 Lin J T, Yu X Z, Cui D J. et al . A multicentre, randomized, controlled trial of oseltamivir in the treatment of influenza in a high-risk Chinese population.  Curr Med Res Opin. 2006;  22 (1) 75-82
• 17 Machado C M, Boas L S, Mendes A V. et al . Use of Oseltamivir to control influenza complications after bone marrow transplantation.  Bone Marrow Transplant. 2004;  34 (2) 111-114
• 18 McGeer A, Green K, Plevneshi A. et al, for the Toronto Invasive Bacterial Diseases Network . Antiviral therapy and outcomes of influenza requiring Hospitalization in Ontario, Canada.  Clin Infect Dis. 2007;  45 (12) 1568-1575
• 19 Meier C R, Napalkow P N, Wegmüller Y. et al . Population-based study on incidence, risk factors, clinical complications and drug utilisation associtaed with influenza in the United Kingdom.  Eur J Clin Microbiol Infect Dis. 2000;  19 834-842
• 20 Monto A S, McKimm-Breschkin J L, Macken C. et al . Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use.  Antimicrob Agents Chemother. 2006;  50 (7) 2395-2402
• 21 Nichols W G, Guthrie K A, Corey L. et al . Influenza infections after hematopoietic stem cell transplantation: risk factors, mortality, and the effect of antiviral therapy.  Clin Infect Dis. 2004;  39 (9) 1300-1306
• 22 Nicholson K G, Aoki F Y, Vrooman P S. et al . Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group.  Lancet. 2000;  355 1845-1850
• 23 Nordstrom B L, Sung I, Suter P. et al . Risk of pneumonia and other complications of influenza-like illness in patients treated with oseltamivir.  Curr Med Res Opin. 2005;  21 761-768
• 24 Patriarca P A, Weber J A, Meissner M K. et al . Use of influenza vaccine in nursing homes.  J Am Geriatr Soc. 1985;  33 (7) 463-466
• 25 Patriarca P A, Weber J A, Parker R A. et al . Risk factors for outbreaks of influenza in nursing homes. A case-control study.  Am J Epidemiol. 1986;  124 (1) 114-119
• 26 Peters Jr P H, Gravenstein S, Norwood P. et al . Long-term use of oseltamivir in the prophylaxis of influenza in household contacts. A randomized controlled trial.  Journal of the American Geriatric Society. 2001;  49 1025-1031
• 27 Shugarman L R, Hales C, Setodji C M. et al . The influence of staff and resident immunization rates on influenza-like illness outbreaks in nursing homes.  J Am Med Dir Assoc. 2006;  7 (9) 562-567
• 28 Simonsen L, Taylor R J, Viboud C. et al . Mortality benefits of influenza vaccination in elderly people: an ongoing controversy.  Lancet Infect Dis. 2007;  7 658-666
• 29 Stevenson C G, McArthur M A, Naus M. et al . Prevention of influenza and pneumococcal pneumonia in Canadian long-term care facilities: how are we doing?.  CMAJ. 2001;  164 (10) 1413-1419
• 30 Thompson W W, Shay D K, Weintraub E. et al . Influenza-associated hospitalizations in the United States.  JAMA. 2004;  292 (11) 1333-1340
• 31 Treanor J J, Hayden F G, Vrooman P S. et al . Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group.  JAMA. 2000;  283 (8) 1016-1024
• 32 Uphoff H, Groniewicz I, Soriano M. et al . A surveillance system for the real-time reporting of influenza activity.  Dis Manage Health Outcomes. 2004;  12 (3) 197-206
• 33 Ward P, Small I, Smith J. et al . Oseltamivir (Tamiflu) and its potential for use in the event of an influenza pandemic.  J Antimicrob Chemother. 2005;  55 Suppl 1 i5-i21
• 34 Welliver R, Monto A S, Carewicz O. et al . Effectiveness of oseltamivir in preventing influenza in household contacts: a randomized controlled trial.  JAMA. 2001;  285 (6) 748-754
• 35 Whitley R J, Hayden F G, Reisinger K S. et al . Oral oseltamivir treatment of influenza in children.  Pediatr Infect Dis J. 2001;  20 (2) 127-33 , Erratum in: Pediatr Infect Dis J 2001; 20(4): 421